Upjohn price increases
Executive Summary
Prices to wholesalers of the anxiolytic Xanax and hypnotic Halcion raised 7%, representing the second round of price hikes for the two benzodiazepine products this year; in February Upjohn raised prices for the two products by about 14%. In addition, Upjohn is also increasing prices for Micronase and the NSAID Ansaid by 6%. The price increases appear to be a response to flattening sales volume. In the second quarter, Upjohn reported a decline in sales of Xanax, Halcion and Micronase. Corporate sales increased only 2% in the quarter.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.